BBZA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
BBZA has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company